Back to article: Advancing host-directed therapy for tuberculosis: new therapeutic insights from the Toxoplasma gondii
FIGURE 1: Summary of the interactions of GRA7 and its mutants with ASC, PLD1, TRAF6, and PKCα.
Back to article: Advancing host-directed therapy for tuberculosis: new therapeutic insights from the Toxoplasma gondii
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.